FindTrial
Sign In

A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFECT OF ERANDADI TAILA AND BALA TAILA MATRA BASTI IN MANAGEMENT OF SUKHAPRASAV

A comparative clinical study to evaluate the effect of erandadi taila and bala taila matra basti in the management of sukhaprasav - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093328
Enrollment
40
Registered
2025-08-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O80- Encounter for full-term uncomplicated delivery

Interventions

None listed

Sponsors

Dr Trisha Verma
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Primigravida completed 37 weeks uncomplicated cases of pregnancy single intrauterine gestation with adequate pelvis pregnant women willing for the trial

Exclusion criteria

Exclusion criteria: Pregnant women not willing for trial. History of medical disorders during pregnancy such as; gestational diabetes mellitus ,pulmonary disease, renal disease, thyroid disorders, psychiatric illness, cardiac?disease, epilepsy, pre- eclampsia, eclampsia, malaria and HIV,bad obstetric?history. Absolute indication of caesarean section such as; central placenta praevia, contracted pelvis or cephalo pelvic disproportion, pelvic mass, advanced carcinoma cervix and vaginal obstruction. 4. Anorectal diseases-fissure,hemorrhoids,fistula.

Design outcomes

Primary

MeasureTime frame
NORMAL DELEVERED BABY WITHOUT COMPLICATION.Timepoint: 7 DAYS—

Secondary

MeasureTime frame
NORMAL DELEVERED BABY WITHOUT COMPLICATION.Timepoint: 24hr to 36hr—

Countries

India

Contacts

Public ContactDr Trisha Verma

Shri Babu Singh Jay Singh Ayurvedic Medical College and Hospital

drsmmulla@hotmail.com7588627408

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026